Raymond W. Urbanski - Aug 13, 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
CHIEF DEVELOPMENT OFFICER
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Stock symbol
SLNO
Transactions as of
Aug 13, 2024
Transactions value $
$0
Form type
4
Date filed
8/23/2024, 07:16 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Stock option (right to buy) Award $0 +145K $0.00 145K Aug 13, 2024 Common Stock 145K $49.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the Option shall vest on August 12, 2025 and one forty-eighth of the shares subject to the Option shall vest each month thereafter on the same day of the month, subject to the Reporting Person continuing to be a Service Provider through each such date..